• search

Wockhardt to raise USD 800 mn to fund overseas acquisitions

Written by: Staff

Mumbai, Mar 16 (UNI) Pharma major Wockhardt Ltd will raise USD 800 million in one or more tranches to fund its overseas acquisitions through an issue of equity-related securities.

Having received its shareholders' approval for the same, Wockhardt informed the BSE that it has also received authorisation from its shareholders to increase the FII holding in the company to 49 per cent.

''Wockhardt's ability to create value through acquisitions is well known,'' said its chairman Habil Khorakiwala, adding ''these approvals reaffirm our shareholder's confidence in our expertise and empower us to seize global opportunities quickly.'' Europe has now become Wockhardt's largest market having overtaken India, while the US has become the company's fastest growing market.

The company also informed the BSE that its shareholders have approved the appointment of Huzaifa Khorakiwala and Dr Murtaza Khorakiwala as executive directors of the company.

Huzaifa Khorakiwala heads the company's global animal healthcare business and corporate administration, while Dr Murtaza Khorakiwala, is in-charge of global bio-tech and API (active pharmaceutical ingredients) businesses.


For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more